Abstract Ferric carboxymaltose (Ferinject®, Injectafer®) is an intravenous iron preparation
approved in numerous countries for the treatment of iron deficiency. A single high dose of …

Objective We aimed at comparing the efficacy of intravenous and oral iron supplementations
for the treatment of iron deficiency (ID) in patients with heart failure (HF). Methods We …

Introduction and objectives To evaluate the effect of iron deficiency and anemia on
submaximal exercise capacity in patients with chronic heart failure. Methods We undertook a …

Introduction and objectives Although heart failure negatively affects the health-related
quality of life of Spanish patients there is little information on the clinical factors associated …

Background Reduced kidney function is common among patients with heart failure. In
patients with heart failure and/or kidney disease, iron deficiency is an independent predictor …

With the challenge of optimizing iron delivery, new intravenous (iv) iron–carbohydrate
complexes have been developed in the last few years. A good example of these new …

Background Anemia is highly prevalent in heart failure (HF) patients. However, the
prevalence, clinical impact and prognostic factor of anemia in heart failure patients is widely …

Whether the anemia increases the risk of mortality in patients with acute heart failure (AHF)
remains unclear. This study aims to explore the relationship between anemia and outcomes …

Iron deficiency is the leading cause of anaemia and is highly prevalent in patients with
chronic heart failure (CHF). Iron deficiency, with or without anaemia, can be corrected with …

Aims A longitudinal and comprehensive analysis of health‐related quality of life (HRQOL)
was performed during hospitalization for heart failure (HF) or soon after discharge. Methods …